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Butyrophenone compounds belong to the group of "major tranquillizers" (neuroleptics). Representatives of this 
group are used both in human (droperidol) and animal (azaperone) practice (Green, 1982). Azaperone (4'-fluoro-4(2- 
pyridyl-l-piperafinyl)-butyrophenone) is widely used in pigs as a sedative when physical restraint or diagnostic 
procedures are required. In addition, the drug is frequently employed in combination with the veterinary analogue of 
etomidate, metomidate (methyl-l-(a-methylbenzyl)imidazol-5-carboxyl-hydrochloride), which provides adequate 
analgesia for short-term surgical procedures in pigs. In recent years several investigators have started to use this 
combination either for induction and/or  as an anaesthetic regimen for physiological preparations, which demands for 
a better understanding of the cardiovascular ctions of these agents. We therefore studied the effects of azaperone (5 
mg.kg-1, i.m.) alone and after addition of metomidate (6 mg.kg-!, i.v.) in 8 instrumented conscious pigs (Duncker et 
~., 1988). Fifteen minutes after administration of azaperone arterial blood pressure was ma~'kedly decreased, which 
was mainly due to systemic vasodilatation. Although cardiac output was only slightly reduced there was a marked 
redistribution i  favour of the arteriovenous anastomoses at the expense of the nutritional channels (cappillaries). 
Flow to the brairt was maintained, but to the left ventricle decreased parallel to the fall in arterial blood pressure (see 
table). Addition of metomidate had no effect on cardiac output. Therefore the increase in blood pressure must have 
resulted from system/c vasoconstriction. The latter was most noticeable in the brain, left ventricle and skeletal muscle. 
We conclude that in the doses used, azaperone alone but also in combination with metomidate has only a moderate 
effect on cardiac output. However, it causes a profound redistribution i  favour of the arteriovenous anastomoses, 
which may explain the hypothermia that is observed with this drug (Green, 1982). 
Conscious Azaperone Azaperone 
metomidate 
Systemic haemodynamics 
heart rate(beats/min) 108 + 2 116 +10 91 + 6 *+ 
mean arterial blood pressure (mmHg) 90 + 5 61 + 7 * 68 4. 5 * 
cardiac output(l/min) 2.3 4- 0.1 2.1 4- 0.1 2.0 4- 0.1 
arteriovenous anastomotic flow (l/min) 0.06 4- 0.01 0.44 4- 0.04 * 0.59 4- 0.09 * 
nutrient cardiac output(i/min) 2.2 4- 0.1 1.6 4- 0.1 * 1.4 4- 0.1 * 
Regional blood flows (m! / min /100 g) 
brain 74 4- 4 74 4- 4 35 4- 3"+ 
left ventricle 132 4- 6 94 4-11" 74 4- 9 * 
kidneys 366 4- 36 244 4- 40 * 252 4- 34" 
skeletal muscle 13.6 4- 4.7 8.3 4- 2.6 3.2 4- 0.3 * 
skin 6.8 4- 1.0 2.0 4- ,3.3 * 1.1 4- 0.3 *+ 
* P < 0.05 vs conscious; + P < 0.05 vs azaperone 
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